Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

37.91
-0.4000-1.04%
Pre-market: 37.67-0.2410-0.64%07:31 EDT
Volume:21.56M
Turnover:823.15M
Market Cap:169.27B
PE:9.47
High:38.77
Open:38.05
Low:37.89
Close:38.31
52wk High:64.16
52wk Low:35.12
Shares:4.47B
Float Shares:3.19B
Volume Ratio:1.55
T/O Rate:0.68%
Dividend:1.72
Dividend Rate:4.54%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:5.20
PE(LYR):10.47

Loading ...

Novo Nordisk (0QIU) Receives a Hold from Bank of America Securities

TIPRANKS
·
Sep 26

Novo Bets on Next Chapter While Eli Lilly Extends Its GLP-1 Dominance

Deep News
·
Sep 25

After Capital-Markets Day Flop, Novo Strikes Licensing Deal That Sends a Swedish Company's Stock Soaring

Dow Jones
·
Sep 25

Novo Nordisk Licenses Nanexa Drug Delivery Technology

MT Newswires Live
·
Sep 25

Cboe data shows mixed options sentiment in Novo Nordisk with shares up 0.96%

TIPRANKS
·
Sep 25

Novo Nordisk A/S Series B Stock Rises Thursday, Outperforms Market

Dow Jones
·
Sep 25

Pharmaceutical Stocks Jump. Moderna, Eli Lilly up over 3%; Novavax, Pfizer up Around 2%; Merck, Novo Nordisk up over 1%

Tiger Newspress
·
Sep 24

Novo Nordisk's new strategy hinges on something it cannot manufacture: investor confidence

Deep News
·
Sep 24

Morning Brief | October Hike Odds Near Seventy Percent As Nasdaq Falls Over One Percent; Cybersecurity Bucks The Trend, TSMC To Lift Prices Three To Six Percent Next Year

Options & Short Sell
·
Sep 24

Novo Nordisk A/S Stock (NVO) Closed Down by 3.12% on Sep 23: Key Drivers Unveiled

TradingKey
·
Sep 24

Movement Alert|Novo-Nordisk A/S Falls 3.02% in Regular Trading, Capital Markets Day Fallout Continues as CEO Admits Need to Rebuild Investor Confidence

Market Focus
·
Sep 24

Novo Nordisk A/S Series B Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Sep 24

Novo Nordisk says CagriSema delivers ‘superior’ weight loss in REIMAGINE 5 trial

TIPRANKS
·
Sep 23

The Stock Market is Sleeping on the Next Big AI Catalyst

Dow Jones
·
Sep 23

Novo Nordisk Gets Regulatory Nod in Singapore for Wegovy Treatment of Certain Liver Ailments

MT Newswires Live
·
Sep 23

Novo Nordisk Open to Direct New York Listing, CEO Doustdar Tells FT

Reuters
·
Sep 23

Market Chatter: Novo Nordisk Mulls Direct NYSE Listing to Boost US Profile

MT Newswires Live
·
Sep 23

Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO) and Alcon (ALC)

TIPRANKS
·
Sep 23

Cboe data shows mixed options sentiment in Novo Nordisk with shares down 0.89%

TIPRANKS
·
Sep 23

European Pharma Leaders Push for National Reforms to Boost Investment

Dow Jones
·
Sep 22